Seoul, South Korea

Mi-Gyeong Lee

This inventor holds 1 USPTO granted patent. Top assignee: Elcom Biotechnology, Co. Ltd.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mi-Gyeong Lee. Retrieved from https://idiyas.com/inventor/mi-gyeong-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mi-Gyeong Lee: Innovator in Neurodegenerative Disease Treatment

Introduction

Mi-Gyeong Lee is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. Her innovative work has garnered attention and respect within the scientific community.

Latest Patents

Mi-Gyeong Lee holds a patent for "Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for treatment of neurodegenerative disease." This patent represents a crucial advancement in the search for effective treatments for conditions that affect cognitive function and overall brain health.

Career Highlights

Mi-Gyeong Lee is currently employed at Elcom Biotechnology Co., Ltd. Her role at the company allows her to focus on research and development in the pharmaceutical sector. Her dedication to innovation has positioned her as a key player in her field.

Collaborations

Mi-Gyeong Lee collaborates with notable colleagues, including Young-Joong Kim and Sang-Hyun Sung. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in biotechnology.

Conclusion

Mi-Gyeong Lee's work in developing pharmaceutical solutions for neurodegenerative diseases highlights her commitment to improving health outcomes. Her contributions are paving the way for future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…